LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-06-29
Case ID: NM_198253.2_c.2781A_G_20260629_222602
Framework: ACMG/AMP 2015
Variant classification summary

NM_198253.2:c.2781A>G

TERT  · NP_937983.2:p.(Leu927=)  · NM_198253.2
GRCh37: chr5:1264581 T>C  ·  GRCh38: chr5:1264466 T>C
Gene: TERT Transcript: NM_198253.2
Final call
VUS
PM2 supporting BP7 supporting benign
All criteria require review: For research and educational purposes only.
Gene
TERT
Transcript
NM_198253.2
Protein
NP_937983.2:p.(Leu927=)
gnomAD AF
1.4872450149406155e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
NM_198253.2:c.2781A>G (p.Leu927=) in TERT is a synonymous variant with extremely low population frequency (gnomAD v4.1 AF = 0.00149%, 24/1,613,722 alleles; absent from gnomAD v2.1), meeting PM2 at supporting strength.
2
SpliceAI predicts no splicing alteration (max delta = 0.00), consistent with a silent variant, meeting BP7 at supporting_benign strength.
3
PVS1 is not met as this synonymous variant does not qualify as a null variant per the ClinGen SVI PVS1 decision framework (PMC6185798). Computational evidence is insufficient for PP3 or BP4. No variant-specific functional studies, case-control data, segregation data, or de novo observations are available. ClinVar reports mixed classifications (Uncertain significance, Likely benign, Benign) from single submitters without expert panel consensus.
4
With one supporting pathogenic criterion (PM2) and one supporting benign criterion (BP7), the net evidence weight is indeterminate. This variant is classified as a Variant of Uncertain Significance.
Final determination: Generic ACMG/AMP 2015 fallback rules do not meet benign, likely benign, likely pathogenic, or pathogenic combination thresholds, so the variant is classified as Variant of Uncertain Significance.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met NM_198253.2:c.2781A>G is a synonymous variant (p.Leu927=) that does not fall into the PVS1 null-variant buckets of nonsense, frameshift, or canonical ±1,2 splice consensus variants per the ClinGen SVI PVS1 framework (PMC6185798).
pvs1_generic_framework
PS1 N/A Synonymous variant with no amino acid change; PS1 requires a different nucleotide change producing the same amino acid change as an established pathogenic variant.
PS2 Not assessed No de novo observation with confirmed paternity and maternity has been reported for this variant.
PS3 Not assessed No well-established in vitro or in vivo functional studies supporting a damaging effect have been identified for this specific synonymous variant.
PS4 Not met No case-control data demonstrate significantly increased prevalence of this variant in affected individuals. ClinVar-associated PMIDs (20301408, 20301779, 26389258, 26389333) are GeneReviews/PDQ summaries that do not mention this specific variant.
clinvar
PS5 Not met No reputable source has recently reported this variant as pathogenic. ClinVar aggregate classification is Uncertain significance with mixed submissions (2 US, 2 LB, 1 B); no expert panel consensus exists.
clinvar
PM1 Not met This variant does not lie in a statistically significant mutational hotspot per hotspot analysis, and no critical functional domain has been specifically implicated at codon 927.
PM2 Met This variant is extremely rare in population databases, with an allele frequency of 0.00149% (24/1,613,722 alleles) in gnomAD v4.1 and absent from gnomAD v2.1, well below the 0.1% PM2 threshold.
gnomad_v4 gnomad_v2
PM5 N/A Synonymous variant with no amino acid change; cannot evaluate same-residue pathogenic missense comparator per PM5 semantics.
PM6 Not assessed No de novo observation (with or without confirmed paternity) has been reported for this variant.
PP1 Not assessed No co-segregation data with disease in multiple affected family members has been reported for this variant.
PP2 N/A PP2 is specific to missense variants in genes with a low rate of benign missense variation. NM_198253.2:c.2781A>G is a synonymous (silent) variant, not a missense change.
PP3 Not met Multiple lines of computational evidence do not support a deleterious effect. SpliceAI predicts no splicing impact (max delta = 0.00). REVEL, BayesDel, and HCI prior scores are unavailable for this variant.
spliceai
PP4 Not assessed No patient phenotype or family history data are available to determine whether the clinical presentation is highly specific for a TERT-associated disorder.
PP5 Not met Of the four ClinVar-associated PMIDs flagged as PP5 candidates (GeneReviews/PDQ summaries: 20301408, 20301779, 26389258, 26389333), none mention NM_198253.2:c.2781A>G. These are gene-level reviews of TERT-associated disorders and do not constitute variant-specific evidence.
clinvar
BA1 Not met The population allele frequency of 0.00149% in gnomAD v4.1 is far below the 1% BA1 threshold.
gnomad_v4
BS1 Not met The population allele frequency of 0.00149% in gnomAD v4.1 is far below the 0.3% BS1 threshold.
gnomad_v4
BS2 Not met No homozygotes have been observed in gnomAD v4.1 (24 heterozygous alleles among 1,613,722 total alleles), failing to meet the requirement for observation in a healthy adult homozygous state.
gnomad_v4
BS3 Not assessed No well-established in vitro or in vivo functional studies demonstrating no damaging effect have been identified for this specific synonymous variant.
BS4 Not assessed No family segregation data are available to evaluate lack of segregation with disease.
BP1 N/A BP1 is specific to missense variants in genes where truncating variants are the primary disease mechanism. NM_198253.2:c.2781A>G is a synonymous variant, not a missense change.
BP2 Not assessed No data on observation in trans with a dominant pathogenic variant are available.
BP4 Not met Insufficient computational evidence to meet the 'multiple lines' threshold. SpliceAI predicts no splicing impact (delta = 0.00), but REVEL, BayesDel, and nucleotide conservation scores are unavailable for this variant.
spliceai
BP5 Not assessed No data on observation in a case with an alternate molecular basis for disease are available.
BP6 Not met ClinVar contains one benign and two likely benign single-submitter classifications, but these lack expert panel review or a published assertion from a reputable source with unavailable supporting evidence.
clinvar
BP7 Met NM_198253.2:c.2781A>G is a synonymous variant (p.Leu927=). SpliceAI predicts no impact on splicing with a maximum delta score of 0.00, consistent with a silent variant unlikely to alter gene product or splicing.
spliceai
BP3 N/A Skipped per directive; this variant is a substitution, not an in-frame indel in a repetitive region.
PM3 N/A Skipped per directive; TERT-associated disorders follow autosomal dominant or autosomal recessive inheritance patterns requiring specific trans/phase data not available for this assessment.
PM4 N/A Skipped per directive; this variant is a single-nucleotide substitution, not a protein-length-altering change.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.